Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment
Lung cancers, the number one cancer killer, can be broadly divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC being the most commonly diagnosed type. Anticancer agents for NSCLC suffer from various limitations that can be partly overcome by the application...
Main Authors: | Noratiqah Mohtar, Thaigarajan Parumasivam, Amirah Mohd Gazzali, Chu Shan Tan, Mei Lan Tan, Rozana Othman, Siti Sarah Fazalul Rahiman, Habibah A. Wahab |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3539 |
Similar Items
-
Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
by: S. Aishah A. Razak, et al.
Published: (2021-01-01) -
In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels
by: Xavier M, et al.
Published: (2019-11-01) -
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
by: Ibrahim M. Abdulbaqi, et al.
Published: (2021-07-01) -
Carbon Nanotubes as Versatile Devices for Detoxification and Cellular Entry
by: Donkor, David Apraku
Published: (2012) -
Proof of concept : the effectiveness of disinfectant tunnel as potential measure against COVID-19
by: Noratiqah Mohtar, et al.
Published: (2021)